References
- Zee D S. Perspectives on the pharmacotherapy of vertigo. Otolaryngol Head Neck Surg 1985; 111: 609–12
- Takeda N, Morita M, Hasegawa S, Horii A, Kubo T, Matsunaga T. Neuropharmacology of motion sickness and emesis. Acta Otolaryngol (Stockh) 1993; 10–5, Suppl. 501
- Mitchell D, Well C, Hoch N, Lind K, Woods S C, Mitchell L K. Poison induced pica in rats. Physiol Be-hav 1976; 17: 691–7
- Morita M, Takeda N, Kubo T, Yamatodani A, Wada H, Matsunaga T. Effects of anti-motion sickness drugs on motion sickness in rats. ORL 1988; 50: 330–3
- Morita M, Takeda N, Kubo T, Matsunaga T. Pica as an index of motion sickness in rat. ORL 1988; 50: 188–92
- Sansom A J, Darlington C L, Smith P F, Gilchrist D PD, Keenan C J, Kenyon R. Injections of calmidazolium chloride into the ipsilateral medial vestibular nucleus of fourth ventricle reduce spontaneous ocular nystagmus following unilateral labyrinthectomy in guinea pigs. Exp Brain Res 1993; 93: 271–8
- Laurikainen E A, Miller J M, Quirk W S, et al. Betahistine-induced vascular effects in the rat cochlea. Am J Otol 1993; 14: 24–30
- Laurikainen E A, Miller J M, Nutall A L, Quirk W S. The vascular mechanism and site of action of betahistine in the inner ear in guinea pig. 1994, In Press
- Leurs R, Timmerman H. The histamine H3-receptor: a target for developing new drugs. Progress in drug research, E Jucker. Birkhäuser Verlag, Basel/Boston/Berlin 1992; Vol. 39: 127–65
- Serafin M, Khateb A, Vibert N, Vidal P P, Muhlethaler M. Medial vestibular nucleus in the guinea-pig: histaminergic receptors. I. An in vivo study. Exp. Brain Res 1993; 93: 242–8
- Wada H, Inazaki N, Yamatodani A, Watanabe T. Is the histaminergic neuron system a regulatory center for whole-brain activity?. Trends Neurosci 1991; 1: 415–8
- Yabe T, De Waele C, Serafin M, et al. Medial vestibular nucleus in the guinea-pig: histaminergic receptors. II. An in vivo study. Exp Brain Res 1993; 93: 249–58
- Lin J S, Sahai K, Vanni-Mercier G, et al. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3 -receptor ligands. Brain Res 1990; 523: 325–30
- Arrang J M, Garbarg M, Quack T T, Tuonga M DT, Yeramin E, Schwartz J C. Action of betahistine and histamine receptors in the brain. Eur J Pharmacol 1985; 111: 73–84